Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
27,691,200
-
Total 13F shares
-
13,850,911
-
Share change
-
+4,517,152
-
Total reported value
-
$115,652,682
-
Put/Call ratio
-
170%
-
Price per share
-
$8.35
-
Number of holders
-
52
-
Value change
-
+$37,785,610
-
Number of buys
-
46
-
Number of sells
-
6
Institutional Holders of FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) as of Q2 2020
As of 30 Jun 2020 FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) had 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 13,850,911 shares of stock of the company.
Largest 10 holders included Southpoint Capital Advisors LP, Avoro Capital Advisors LLC, Sonic Fund II, L.P., EVENTIDE ASSET MANAGEMENT, LLC, 683 Capital Management, LLC, BlackRock Inc., Solas Capital Management, LLC, STATE STREET CORP, GRANAHAN INVESTMENT MANAGEMENT INC/MA, and NORTHERN TRUST CORP.
This table shows 52 institutional shareholders of the security as of 30 Jun 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.